Strategies for generating less toxic P-selectin inhibitors: Pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits

被引:15
作者
Ananthula, Ravi Shekar [1 ]
Ravikumar, Muttineni [1 ]
Pramod, A. B. [1 ]
Madala, Kishore Kumar [1 ]
Mahmood, S. K. [2 ]
机构
[1] Technocrats Ind Estate, Hyderabad 500037, Andhra Pradesh, India
[2] Osmania Univ, Dept Bot, Environm Microbial Lab, Biomformat Div, Hyderabad 500007, Andhra Pradesh, India
关键词
Virtual screening; Pharmacophore; Docking; P-selectin; DHOD;
D O I
10.1016/j.jmgm.2008.09.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This paper describes the generation of ligand-based as well as structure-based models and virtual screening of less toxic P-selectin receptor inhibitors. Ligand-based model, 3D-pharmacophore was generated using 27 quinoline salicylic acid compounds and is used to retrieve the actives of P-selectin. This model contains three hydrogen bond acceptors (HBA), two ring aromatics (RA) and one hydrophobic feature (HY). To remove the toxic hits from the screened molecules, a counter pharmacophore model was generated using inhibitors of dihydrooratate dehydrogenase (DHOD), an important enzyme involved in nucleic acid synthesis, whose inhibition leads to toxic effects. Structure-based models were generated by docking and scoring of inhibitors against P-selectin receptor, to remove the false positives committed by pharmacophore screening. The combination of these ligand-based and structure-based virtual screening models were used to screen a commercial database containing 538,000 compounds. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:546 / 557
页数:12
相关论文
共 41 条
[1]   Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine [J].
Bienvenu, JG ;
Tanguay, JF ;
Théorêt, JF ;
Kumar, A ;
Schaub, RG ;
Merhi, Y .
CIRCULATION, 2001, 103 (08) :1128-1134
[2]   The adhesion molecule P-selectin and cardiovascular disease [J].
Blann, AD ;
Nadar, SK ;
Lip, GYH .
EUROPEAN HEART JOURNAL, 2003, 24 (24) :2166-2179
[3]   Platelet P-selectin facilitates atherosclerotic lesion development [J].
Burger, PC ;
Wagner, DD .
BLOOD, 2003, 101 (07) :2661-2666
[4]   Leukocytosis and ischemic vascular disease morbidity and mortality - Is it time to intervene? [J].
Coller, BS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (04) :658-670
[5]   Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists [J].
Edwards, BS ;
Bologa, C ;
Young, SM ;
Balakin, KV ;
Prossnitz, ER ;
Savchuck, NP ;
Sklar, LA ;
Oprea, TI .
MOLECULAR PHARMACOLOGY, 2005, 68 (05) :1301-1310
[6]   P-selectin-dependent inhibition of thrombosis during venous stasis [J].
Eppihimer, MJ ;
Schaub, RG .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) :2483-2488
[7]  
FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682
[8]   Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy [J].
Friesner, RA ;
Banks, JL ;
Murphy, RB ;
Halgren, TA ;
Klicic, JJ ;
Mainz, DT ;
Repasky, MP ;
Knoll, EH ;
Shelley, M ;
Perry, JK ;
Shaw, DE ;
Francis, P ;
Shenkin, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1739-1749
[9]   A journey with platelet P-selectin: The molecular basis of granule secretion, signalling and cell adhesion [J].
Furie, B ;
Furie, BC ;
Flaumenhaft, R .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (01) :214-221
[10]  
Good A, 2001, Curr Opin Drug Discov Devel, V4, P301